Effects of Intramyocardial Administration of Slow-Release Basic Fibroblast Growth Factor on Angiogenesis and Ventricular Remodeling in a Rat Infarct Model
Background Basic fibroblast growth factor (bFGF) stimulates neoangiogenesis. Incorporation into biodegradable gelatin hydrogels provides the sustained release of bFGF. The effects of intramyocardial injections of slow-release bFGF on neoangiogenesis in a rat model of infarction were investigated. Me...
Gespeichert in:
| Veröffentlicht in: | Circulation Journal 2006, Vol.70(4), pp.471-477 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 477 |
|---|---|
| container_issue | 4 |
| container_start_page | 471 |
| container_title | Circulation Journal |
| container_volume | 70 |
| creator | Shao, Zhan-Qiang Takaji, Kentaro Katayama, Yukihiro Kunitomo, Ryuji Sakaguchi, Hisashi Lai, Zhong-Fang Kawasuji, Michio |
| description | Background Basic fibroblast growth factor (bFGF) stimulates neoangiogenesis. Incorporation into biodegradable gelatin hydrogels provides the sustained release of bFGF. The effects of intramyocardial injections of slow-release bFGF on neoangiogenesis in a rat model of infarction were investigated. Methods and Results Myocardial infarction was induced in rats using coronary artery ligation. A total of 124 rats received an intramyocardial injection of 20 μg of bFGF, the same amount of bFGF incorporated into gelatin hydrogel (bFGF + gel), gelatin hydrogel (gel) or saline. Ventricular function was evaluated by echocardiography 2 or 4 weeks later. Morphometric and histological analyses were used to evaluate infarct size, vascular density and myocardial apoptosis. Capillary density in the infarct border zone was higher in the bFGF and bFGF + gel groups than in the saline and gel groups at 4 weeks (p |
| doi_str_mv | 10.1253/circj.70.471 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67786624</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67786624</sourcerecordid><originalsourceid>FETCH-LOGICAL-c576t-6b252ff1481e630a49c1a70fbd6ca35d06dd9816e727a03966e2a2540ea7330b3</originalsourceid><addsrcrecordid>eNpNkU1v2zAMho1hw_qx3XYedNqpzvRhS_YxK5q2QIcB2cfVoGUqVSBLnaSg6F_Zr53SBOsuokA-fEnwraoPjC4Yb8VnbaPeLhRdNIq9qk6ZaFTddJy-fv7Luu8acVKdpbSllPe07d9WJ0y2sm2lOq3-XBmDOicSDLn1OcL8FDTEyYIjy2m23qaSzDb4PfHdhcd6jQ4hIfkCyWqysmMMo4OUyXUMj_merEDnEEnpWPqNDRv0mGwi4CfyC8sIq3cOIlnjHCZ01m-I9QTIGnLZwEDUmXzdV95Vbwy4hO-P8bz6ubr6cXlT3327vr1c3tW6VTLXcuQtN4Y1HUMpKDS9ZqCoGSepQbQTldPUd0yi4gqo6KVEDrxtKIISgo7ivPp00H2I4fcOUx5mmzQ6Bx7DLg1SqU5K3hTw4gDqGFKKaIaHaGeITwOjw96L4dmLQdGheFHwj0fd3Tjj9AIfj1-A5QHYpgwb_AdAzFY7_E_t8BTRl9o9xAG9-AuQRp-j</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67786624</pqid></control><display><type>article</type><title>Effects of Intramyocardial Administration of Slow-Release Basic Fibroblast Growth Factor on Angiogenesis and Ventricular Remodeling in a Rat Infarct Model</title><source>J-STAGE Free</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Shao, Zhan-Qiang ; Takaji, Kentaro ; Katayama, Yukihiro ; Kunitomo, Ryuji ; Sakaguchi, Hisashi ; Lai, Zhong-Fang ; Kawasuji, Michio</creator><creatorcontrib>Shao, Zhan-Qiang ; Takaji, Kentaro ; Katayama, Yukihiro ; Kunitomo, Ryuji ; Sakaguchi, Hisashi ; Lai, Zhong-Fang ; Kawasuji, Michio</creatorcontrib><description>Background Basic fibroblast growth factor (bFGF) stimulates neoangiogenesis. Incorporation into biodegradable gelatin hydrogels provides the sustained release of bFGF. The effects of intramyocardial injections of slow-release bFGF on neoangiogenesis in a rat model of infarction were investigated. Methods and Results Myocardial infarction was induced in rats using coronary artery ligation. A total of 124 rats received an intramyocardial injection of 20 μg of bFGF, the same amount of bFGF incorporated into gelatin hydrogel (bFGF + gel), gelatin hydrogel (gel) or saline. Ventricular function was evaluated by echocardiography 2 or 4 weeks later. Morphometric and histological analyses were used to evaluate infarct size, vascular density and myocardial apoptosis. Capillary density in the infarct border zone was higher in the bFGF and bFGF + gel groups than in the saline and gel groups at 4 weeks (p<0.001). Arteriolar density was higher in the bFGF + gel group than in the other 3 groups (p<0.05). The bFGF and bFGF + gel groups contained fewer apoptotic cardiomyocytes in the border zone than the saline and gel groups (p<0.01). The bFGF+gel group had thicker (p<0.05) and less expanded infarcts (p<0.01) compared with the saline group at 4 weeks. Conclusions Incorporation of bFGF in gelatin hydrogels enhanced the effects of bFGF on arteriogenesis, ventricular remodeling and cardiac function. (Circ J 2006; 70: 471 - 477)</description><identifier>ISSN: 1346-9843</identifier><identifier>EISSN: 1347-4820</identifier><identifier>DOI: 10.1253/circj.70.471</identifier><identifier>PMID: 16565567</identifier><language>eng</language><publisher>Japan: The Japanese Circulation Society</publisher><subject>Angiogenesis ; Animals ; Apoptosis ; Capillaries - pathology ; Delayed-Action Preparations ; Echocardiography ; Fibroblast Growth Factor 2 - administration & dosage ; Fibroblast Growth Factor 2 - pharmacology ; Fibroblast Growth Factor 2 - therapeutic use ; Hydrogels ; Ischemic heart disease ; Male ; Myocardial Infarction - drug therapy ; Myocardial Infarction - pathology ; Myocardial Infarction - physiopathology ; Myocardial remodeling ; Neovascularization, Physiologic - drug effects ; Rats ; Rats, Sprague-Dawley ; Ventricular Function ; Ventricular Remodeling - drug effects</subject><ispartof>Circulation Journal, 2006, Vol.70(4), pp.471-477</ispartof><rights>2006 THE JAPANESE CIRCULATION SOCIETY</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c576t-6b252ff1481e630a49c1a70fbd6ca35d06dd9816e727a03966e2a2540ea7330b3</citedby><cites>FETCH-LOGICAL-c576t-6b252ff1481e630a49c1a70fbd6ca35d06dd9816e727a03966e2a2540ea7330b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1876,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16565567$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shao, Zhan-Qiang</creatorcontrib><creatorcontrib>Takaji, Kentaro</creatorcontrib><creatorcontrib>Katayama, Yukihiro</creatorcontrib><creatorcontrib>Kunitomo, Ryuji</creatorcontrib><creatorcontrib>Sakaguchi, Hisashi</creatorcontrib><creatorcontrib>Lai, Zhong-Fang</creatorcontrib><creatorcontrib>Kawasuji, Michio</creatorcontrib><title>Effects of Intramyocardial Administration of Slow-Release Basic Fibroblast Growth Factor on Angiogenesis and Ventricular Remodeling in a Rat Infarct Model</title><title>Circulation Journal</title><addtitle>Circ J</addtitle><description>Background Basic fibroblast growth factor (bFGF) stimulates neoangiogenesis. Incorporation into biodegradable gelatin hydrogels provides the sustained release of bFGF. The effects of intramyocardial injections of slow-release bFGF on neoangiogenesis in a rat model of infarction were investigated. Methods and Results Myocardial infarction was induced in rats using coronary artery ligation. A total of 124 rats received an intramyocardial injection of 20 μg of bFGF, the same amount of bFGF incorporated into gelatin hydrogel (bFGF + gel), gelatin hydrogel (gel) or saline. Ventricular function was evaluated by echocardiography 2 or 4 weeks later. Morphometric and histological analyses were used to evaluate infarct size, vascular density and myocardial apoptosis. Capillary density in the infarct border zone was higher in the bFGF and bFGF + gel groups than in the saline and gel groups at 4 weeks (p<0.001). Arteriolar density was higher in the bFGF + gel group than in the other 3 groups (p<0.05). The bFGF and bFGF + gel groups contained fewer apoptotic cardiomyocytes in the border zone than the saline and gel groups (p<0.01). The bFGF+gel group had thicker (p<0.05) and less expanded infarcts (p<0.01) compared with the saline group at 4 weeks. Conclusions Incorporation of bFGF in gelatin hydrogels enhanced the effects of bFGF on arteriogenesis, ventricular remodeling and cardiac function. (Circ J 2006; 70: 471 - 477)</description><subject>Angiogenesis</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Capillaries - pathology</subject><subject>Delayed-Action Preparations</subject><subject>Echocardiography</subject><subject>Fibroblast Growth Factor 2 - administration & dosage</subject><subject>Fibroblast Growth Factor 2 - pharmacology</subject><subject>Fibroblast Growth Factor 2 - therapeutic use</subject><subject>Hydrogels</subject><subject>Ischemic heart disease</subject><subject>Male</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Myocardial Infarction - pathology</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Myocardial remodeling</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Ventricular Function</subject><subject>Ventricular Remodeling - drug effects</subject><issn>1346-9843</issn><issn>1347-4820</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkU1v2zAMho1hw_qx3XYedNqpzvRhS_YxK5q2QIcB2cfVoGUqVSBLnaSg6F_Zr53SBOsuokA-fEnwraoPjC4Yb8VnbaPeLhRdNIq9qk6ZaFTddJy-fv7Luu8acVKdpbSllPe07d9WJ0y2sm2lOq3-XBmDOicSDLn1OcL8FDTEyYIjy2m23qaSzDb4PfHdhcd6jQ4hIfkCyWqysmMMo4OUyXUMj_merEDnEEnpWPqNDRv0mGwi4CfyC8sIq3cOIlnjHCZ01m-I9QTIGnLZwEDUmXzdV95Vbwy4hO-P8bz6ubr6cXlT3327vr1c3tW6VTLXcuQtN4Y1HUMpKDS9ZqCoGSepQbQTldPUd0yi4gqo6KVEDrxtKIISgo7ivPp00H2I4fcOUx5mmzQ6Bx7DLg1SqU5K3hTw4gDqGFKKaIaHaGeITwOjw96L4dmLQdGheFHwj0fd3Tjj9AIfj1-A5QHYpgwb_AdAzFY7_E_t8BTRl9o9xAG9-AuQRp-j</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>Shao, Zhan-Qiang</creator><creator>Takaji, Kentaro</creator><creator>Katayama, Yukihiro</creator><creator>Kunitomo, Ryuji</creator><creator>Sakaguchi, Hisashi</creator><creator>Lai, Zhong-Fang</creator><creator>Kawasuji, Michio</creator><general>The Japanese Circulation Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2006</creationdate><title>Effects of Intramyocardial Administration of Slow-Release Basic Fibroblast Growth Factor on Angiogenesis and Ventricular Remodeling in a Rat Infarct Model</title><author>Shao, Zhan-Qiang ; Takaji, Kentaro ; Katayama, Yukihiro ; Kunitomo, Ryuji ; Sakaguchi, Hisashi ; Lai, Zhong-Fang ; Kawasuji, Michio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c576t-6b252ff1481e630a49c1a70fbd6ca35d06dd9816e727a03966e2a2540ea7330b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Angiogenesis</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Capillaries - pathology</topic><topic>Delayed-Action Preparations</topic><topic>Echocardiography</topic><topic>Fibroblast Growth Factor 2 - administration & dosage</topic><topic>Fibroblast Growth Factor 2 - pharmacology</topic><topic>Fibroblast Growth Factor 2 - therapeutic use</topic><topic>Hydrogels</topic><topic>Ischemic heart disease</topic><topic>Male</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Myocardial Infarction - pathology</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Myocardial remodeling</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Ventricular Function</topic><topic>Ventricular Remodeling - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shao, Zhan-Qiang</creatorcontrib><creatorcontrib>Takaji, Kentaro</creatorcontrib><creatorcontrib>Katayama, Yukihiro</creatorcontrib><creatorcontrib>Kunitomo, Ryuji</creatorcontrib><creatorcontrib>Sakaguchi, Hisashi</creatorcontrib><creatorcontrib>Lai, Zhong-Fang</creatorcontrib><creatorcontrib>Kawasuji, Michio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shao, Zhan-Qiang</au><au>Takaji, Kentaro</au><au>Katayama, Yukihiro</au><au>Kunitomo, Ryuji</au><au>Sakaguchi, Hisashi</au><au>Lai, Zhong-Fang</au><au>Kawasuji, Michio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Intramyocardial Administration of Slow-Release Basic Fibroblast Growth Factor on Angiogenesis and Ventricular Remodeling in a Rat Infarct Model</atitle><jtitle>Circulation Journal</jtitle><addtitle>Circ J</addtitle><date>2006</date><risdate>2006</risdate><volume>70</volume><issue>4</issue><spage>471</spage><epage>477</epage><pages>471-477</pages><issn>1346-9843</issn><eissn>1347-4820</eissn><abstract>Background Basic fibroblast growth factor (bFGF) stimulates neoangiogenesis. Incorporation into biodegradable gelatin hydrogels provides the sustained release of bFGF. The effects of intramyocardial injections of slow-release bFGF on neoangiogenesis in a rat model of infarction were investigated. Methods and Results Myocardial infarction was induced in rats using coronary artery ligation. A total of 124 rats received an intramyocardial injection of 20 μg of bFGF, the same amount of bFGF incorporated into gelatin hydrogel (bFGF + gel), gelatin hydrogel (gel) or saline. Ventricular function was evaluated by echocardiography 2 or 4 weeks later. Morphometric and histological analyses were used to evaluate infarct size, vascular density and myocardial apoptosis. Capillary density in the infarct border zone was higher in the bFGF and bFGF + gel groups than in the saline and gel groups at 4 weeks (p<0.001). Arteriolar density was higher in the bFGF + gel group than in the other 3 groups (p<0.05). The bFGF and bFGF + gel groups contained fewer apoptotic cardiomyocytes in the border zone than the saline and gel groups (p<0.01). The bFGF+gel group had thicker (p<0.05) and less expanded infarcts (p<0.01) compared with the saline group at 4 weeks. Conclusions Incorporation of bFGF in gelatin hydrogels enhanced the effects of bFGF on arteriogenesis, ventricular remodeling and cardiac function. (Circ J 2006; 70: 471 - 477)</abstract><cop>Japan</cop><pub>The Japanese Circulation Society</pub><pmid>16565567</pmid><doi>10.1253/circj.70.471</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1346-9843 |
| ispartof | Circulation Journal, 2006, Vol.70(4), pp.471-477 |
| issn | 1346-9843 1347-4820 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67786624 |
| source | J-STAGE Free; MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Angiogenesis Animals Apoptosis Capillaries - pathology Delayed-Action Preparations Echocardiography Fibroblast Growth Factor 2 - administration & dosage Fibroblast Growth Factor 2 - pharmacology Fibroblast Growth Factor 2 - therapeutic use Hydrogels Ischemic heart disease Male Myocardial Infarction - drug therapy Myocardial Infarction - pathology Myocardial Infarction - physiopathology Myocardial remodeling Neovascularization, Physiologic - drug effects Rats Rats, Sprague-Dawley Ventricular Function Ventricular Remodeling - drug effects |
| title | Effects of Intramyocardial Administration of Slow-Release Basic Fibroblast Growth Factor on Angiogenesis and Ventricular Remodeling in a Rat Infarct Model |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T13%3A57%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Intramyocardial%20Administration%20of%20Slow-Release%20Basic%20Fibroblast%20Growth%20Factor%20on%20Angiogenesis%20and%20Ventricular%20Remodeling%20in%20a%20Rat%20Infarct%20Model&rft.jtitle=Circulation%20Journal&rft.au=Shao,%20Zhan-Qiang&rft.date=2006&rft.volume=70&rft.issue=4&rft.spage=471&rft.epage=477&rft.pages=471-477&rft.issn=1346-9843&rft.eissn=1347-4820&rft_id=info:doi/10.1253/circj.70.471&rft_dat=%3Cproquest_cross%3E67786624%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67786624&rft_id=info:pmid/16565567&rfr_iscdi=true |